Search Results - Mauro Zucchetto

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial

    Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial by Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Bridget K. Wagner, Mauro Zucchetto, Ganesh Raghu, Fernando J. Martínez, Jonathan Goldin, Jeffrey Siegel, Christopher P. Denton

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis

    Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis by Hermine I. Brunner, Nicolino Ruperto, Athimalaipet V Ramanan, Gerd Horneff, Kirsten Minden, Inmaculada Calvo Penadés, Е.I. Alexeeva, Gavin Cleary, Sara Stern, Isabelle Koné‐Paut, María del Rocío Maldonado Velázquez, C. Egla Rabinovich, Agustín Remesal, Clóvis A. Silva, И. П. Никишина, Mauro Zucchetto, Laura Brockwell, Oliver Gordon, Sandra Nagel, Fabrizio De Benedetti, Rubén Cuttica, Maria Elena Rama, Jonathan Akikusa, Jeffrey Chaitow, Cláudio Arnaldo Len, Clóvis A. Silva, Heinrike Schmeling, Rayfel Schneider, Isabelle Koné‐Paut, Markus Hufnagel, Kirsten Minden, Gerd Horneff, Fabrizio De Benedetti, María del Rocío Maldonado Velázquez, Nadina Rubio, Е. И. Алексеева, Agustín Remesal, Alina Boteanu, Rosa Bou, Inmaculada Calvo Penadés, Athimalaipet V Ramanan, Gavin Cleary, Hermine I. Brunner, Ginger Janow, Jennifer E. Weiss, Daniel J. Lovell, Alan Martin, Kabita Nanda, Linda Wagner‐Weiner, Sara Stern, Andrew Zeft, Jason Dare

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: